Option Care Health reported a Q1 2026 revenue shortfall and reduced its full-year 2026 revenue guidance by up to 3.75%, or $225 million, lowering the forecast to $5.675-$5.775 billion from $5.8-$6.0 billion. The company cited increased challenges from the Stelara biosimilar conversion, with patient conversions to other therapies falling below expectations, worsening revenue headwinds from an initially estimated $25-$35 million to $55 million. This sharp revision has prompted Levi & Korsinsky LLP to launch an investigation into potential federal securities law violations. Investors who suffered losses may consider legal action as the situation develops.
Canada's proposed Bill C-22 faces strong opposition from major tech firms like Meta, Apple, and Signal, as well as VPN providers, due to concerns it could force companies to weaken encryption and compromise digital privacy. Industry leaders warn this...
Bill C-22 in Canada faces strong opposition from tech leaders and experts who warn it threatens the digital economy by undermining data privacy and encryption. Quebec's tech sector, especially in AI and cloud infrastructure, could lose investments, t...
Sandisk's stock has surged 476% in 2026, driven by strong demand for storage linked to the AI boom and impressive revenue growth, including a 97% quarter-over-quarter increase to $5.9 billion. The company boasts high profit margins and optimistic Wal...
Altria Group (MO) maintains a diversified portfolio targeting both discount and premium consumers, helping it sustain stable market share despite shifting demand. The company benefits from strong pricing power, margin growth, and shareholder-friendly...
Italy's largest bank, Intesa Sanpaolo, increased its digital asset exposure to about $235 million in Q1 2026, up from $100 million in Q4 2025. The bank added a new $18 million position in XRP through the Grayscale XRP Trust, marking its first direct ...
